LEUVEN, BELGIUM -- (Marketwired) -- 08/20/13 -- (NYSE Euronext: TIG)(NYSE Euronext: TIG),ChondroCelect:ChondroCelect sales EUR 2.3 million, up 55% from H1 2012ChondroCelect obtains national reimbursement in SpainProduct development pipelineADMIRE-CD Phase III trial (Cx601) in complex perianal fistu ...
↧